As of December 2024, Harbin Gloria Pharmaceuticals has a market cap of $864.13M. This makes Harbin Gloria Pharmaceuticals the world's 8849th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $595.22M | -21.51% |
2023 | $758.38M | -1.18% |
2022 | $767.44M | -12.71% |
2021 | $879.24M | -9.06% |
2020 | $966.86M | 5.61% |
2019 | $915.49M | 8.21% |
2018 | $846.00M | -59.36% |
2017 | $2.08B | -16.69% |
2016 | $2.50B | -17.98% |
2015 | $3.05B | 27.37% |
2014 | $2.39B | 41.03% |
2013 | $1.70B | 108.00% |
2012 | $815.38M | - |